Skip to content

Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults

Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07398443
Acronym
MATEY
Enrollment
120
Registered
2026-02-09
Start date
2026-02-17
Completion date
2028-11-30
Last updated
2026-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavioral Economics, Cannabis Smoking, Tobacco Smoking

Brief summary

The multi session experimental study aims to determine dual use patterns of marijuana and tobacco by assessing the impact of price and availability of marijuana and tobacco using a cross price elasticity of demand task. The study will recruit 120 non-treatment seeking emerging young adults (18-25 years) who smoke marijuana and tobacco.

Detailed description

Young adulthood is a crucial time to study substance use disorders which increase cancer risk later in life. It is especially important to understand marijuana and tobacco use as most young adults often use both. Although dual use is related with increased long-term health and behavioral risks, underlying behavioral mechanisms remain unclear. This study aims to address this gap by using rigorous laboratory-based behavioral economic measure including a novel cross-price elasticity of demand (CPED) task and an innovative extension of cue-induced demand to assess cross-cue reactivity to better understand co- use. The results will help lead cessation efforts in this population and reduce cancer risk across the lifespan. Participants (N = 120) will be young adults (age 18-25) endorsing current tobacco and marijuana use and will complete 4 experimental in-person sessions. Following a phone-screen to assess preliminary eligibility, participants will come to the study center for in-person baseline screening. This screening consists of a urine toxicology screen, a breathalyzer test, and self-report questionnaires. The remaining three sessions will be completed in person which mainly consist of cross-cue reactivity sessions, self-report measures, and a qualitative exit interview following the final session.

Interventions

BEHAVIORALCue Reactivity

Participants will be exposed to neutral followed by cannabis or tobacco cues in a fixed sequence while they answer questions about their subjective state. The cues will include everyday items (e.g., eraser) and cannabis-related items (e.g., lighter).

Sponsors

Brown University
Lead SponsorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

1. Males/females who are 18 to 25 years of age 2. Young adults who currently smoke commercial tobacco cigarettes (≥1x weekly in the past 30 days and for the past six months) 3. Young adults who currently smoke marijuana (≥4 times in past 30 days and at least weekly on average for the last six months) 4. Participants must report purchasing their own tobacco and marijuana at least once in the past 6 months 5. Participants must speak, comprehend, and read English.

Exclusion criteria

1. Intention to quit marijuana or tobacco use in the next 30 days 2. Self-reported illicit drug or heavy episodic alcohol use on \>20 days in the past month (excluding marijuana) 3. Individuals who are pregnant or breastfeeding 4. Positive saliva test for recent THC use 5. Breath alcohol level above 0 at any session. 6. Participants who exclusively roll their own tobacco cigarettes

Design outcomes

Primary

MeasureTime frameDescription
Change in self-reported cannabis cravingUp to 40 days post-baseline sessionThis study utilizes a structured cannabis cue exposure paradigm. During cue exposure, participants rate subjective craving on a scale from 0, "Not at all," to 10, "Extremely." Cannabis craving will be assessed following neutral cue exposure and then cannabis cue exposure. The primary outcome will be change in cannabis craving.
Change in self-reported tobacco cravingUp to 40 days post-baseline sessionThis study utilizes a structured tobacco cue exposure paradigm. During cue exposure, participants rate subjective craving on a scale from 0, "Not at all," to 10, "Extremely." Tobacco craving will be assessed following neutral cue exposure and then tobacco cue exposure. The primary outcome will be change in tobacco craving.

Countries

United States

Contacts

CONTACTElizabeth Aston, PhD
elizabeth_aston@brown.edu401-863-6668

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026